Tag: single-cell genome sequencing market share

  • Single-Cell Genome Sequencing Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Single-Cell Genome Sequencing Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Predicted CAGR for the Single-Cell Genome Sequencing Market Over the Forecast Period of 2025 to 2034?

    The single-cell genome sequencing market has expanded rapidly in recent years. It is expected to increase from $2.49 billion in 2024 to $2.84 billion in 2025, at a CAGR of 13.9%. Key drivers of past growth include a better understanding of genetic heterogeneity, growing demand for precision medicine, an uptick in cancer research, the rising prevalence of infectious diseases, and increased healthcare investments.

    The single-cell genome sequencing market is expected to expand rapidly, reaching $5.04 billion by 2029 at a CAGR of 15.4%. The market’s growth is driven by rising prevalence of autoimmune diseases, increasing neurological disorders, government funding, the emergence of contract research organizations (CROs), and growing awareness of scRNA-seq applications. Key trends include technological advancements in single-cell sequencing, development of multi-omics technologies, industry collaborations, innovative solutions, and strategic partnerships.

    What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Market?

    The increasing prevalence of cancer is expected to drive the growth of the single-cell genome sequencing market in the future. Cancer encompasses a wide range of diseases characterized by uncontrolled growth and division of abnormal cells, resulting from genetic changes that affect normal cell function. Given that cancer is a disease marked by genetic alterations, single-cell genome sequencing can reveal the genetic changes occurring in individual cancer cells. For instance, in January 2023, the American Cancer Society, a US-based cancer-fighting organization, reported approximately 1.9 million new cancer cases and 609,360 cancer-related deaths in the US in 2022. Additionally, it is estimated that by 2040, there will be about 27.5 million new cancer cases and 16.3 million cancer deaths. Therefore, the rising prevalence of cancer is anticipated to propel the growth of the single-cell genome sequencing market.

    Explore Comprehensive Insights Into The Global Single-Cell Genome Sequencing Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

    Who Are the Top Companies Driving Innovation and Growth in the Single-Cell Genome Sequencing Market?

    Major companies operating in the single-cell genome sequencing market include:

    • F Hoffmann-La Roche Ltd._x000D_

    • Thermo Fisher Scientific Inc._x000D_

    • DH Life Sciences LLC._x000D_

    • Becton Dickinson And Company (BD)_x000D_

    • Agilent Technologies Inc._x000D_

    What Key Trends Are Currently Impacting the Single-Cell Genome Sequencing Market’s Development?

    Technological advancements are driving growth in the single-cell genome sequencing market, as key players focus on developing state-of-the-art solutions to strengthen their market standing. For instance, in May 2023, Mission Bio Inc., a US-based single-cell multi-omics platform specializing in genotype and phenotype integration for cancer research and biomarker development, launched the Tapestri Genome Editing Solution. This end-to-end analytical product enhances genome editing analysis, offering single-cell insights that could transform efficacy and safety in the next generation of gene-edited drugs.

    Secure Your Global Single-Cell Genome Sequencing Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

    What Are the Core Segments of the Single-Cell Genome Sequencing Market, and How Do They Contribute to Growth?

    The single-cell genome sequencing market covered in this report is segmented –

    1) By Type: Instruments, Reagents

    2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)

    3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas

    4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications

    5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

    Subsegments:

    1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems

    2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents

    Which Geographical Regions Are Pioneering Growth in the Single-Cell Genome Sequencing Market?

    North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Do Experts Define the Scope of the Single-Cell Genome Sequencing Market?

    Single-cell genome sequencing is a potent method for detecting genomic changes like copy number variations (CNVs) and point mutations and revealing cell-to-cell heterogeneity in biological materials. They are employed to investigate both healthy and diseased physiology.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Based Assays Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

    Cell Culture Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Single-Cell Genome Sequencing Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Single-Cell Genome Sequencing Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Predicted CAGR for the Single-Cell Genome Sequencing Market Over the Forecast Period of 2025 to 2034?

    The single-cell genome sequencing market has expanded rapidly in recent years. It is expected to increase from $2.49 billion in 2024 to $2.84 billion in 2025, at a CAGR of 13.9%. Key drivers of past growth include a better understanding of genetic heterogeneity, growing demand for precision medicine, an uptick in cancer research, the rising prevalence of infectious diseases, and increased healthcare investments.

    The single-cell genome sequencing market is expected to expand rapidly, reaching $5.04 billion by 2029 at a CAGR of 15.4%. The market’s growth is driven by rising prevalence of autoimmune diseases, increasing neurological disorders, government funding, the emergence of contract research organizations (CROs), and growing awareness of scRNA-seq applications. Key trends include technological advancements in single-cell sequencing, development of multi-omics technologies, industry collaborations, innovative solutions, and strategic partnerships.

    What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Market?

    The increasing prevalence of cancer is expected to drive the growth of the single-cell genome sequencing market in the future. Cancer encompasses a wide range of diseases characterized by uncontrolled growth and division of abnormal cells, resulting from genetic changes that affect normal cell function. Given that cancer is a disease marked by genetic alterations, single-cell genome sequencing can reveal the genetic changes occurring in individual cancer cells. For instance, in January 2023, the American Cancer Society, a US-based cancer-fighting organization, reported approximately 1.9 million new cancer cases and 609,360 cancer-related deaths in the US in 2022. Additionally, it is estimated that by 2040, there will be about 27.5 million new cancer cases and 16.3 million cancer deaths. Therefore, the rising prevalence of cancer is anticipated to propel the growth of the single-cell genome sequencing market.

    Explore Comprehensive Insights Into The Global Single-Cell Genome Sequencing Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

    Who Are the Top Companies Driving Innovation and Growth in the Single-Cell Genome Sequencing Market?

    Major companies operating in the single-cell genome sequencing market include:

    • F Hoffmann-La Roche Ltd._x000D_

    • Thermo Fisher Scientific Inc._x000D_

    • DH Life Sciences LLC._x000D_

    • Becton Dickinson And Company (BD)_x000D_

    • Agilent Technologies Inc._x000D_

    What Key Trends Are Currently Impacting the Single-Cell Genome Sequencing Market’s Development?

    Technological advancements are driving growth in the single-cell genome sequencing market, as key players focus on developing state-of-the-art solutions to strengthen their market standing. For instance, in May 2023, Mission Bio Inc., a US-based single-cell multi-omics platform specializing in genotype and phenotype integration for cancer research and biomarker development, launched the Tapestri Genome Editing Solution. This end-to-end analytical product enhances genome editing analysis, offering single-cell insights that could transform efficacy and safety in the next generation of gene-edited drugs.

    Secure Your Global Single-Cell Genome Sequencing Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

    What Are the Core Segments of the Single-Cell Genome Sequencing Market, and How Do They Contribute to Growth?

    The single-cell genome sequencing market covered in this report is segmented –

    1) By Type: Instruments, Reagents

    2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)

    3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas

    4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications

    5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

    Subsegments:

    1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems

    2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents

    Which Geographical Regions Are Pioneering Growth in the Single-Cell Genome Sequencing Market?

    North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Do Experts Define the Scope of the Single-Cell Genome Sequencing Market?

    Single-cell genome sequencing is a potent method for detecting genomic changes like copy number variations (CNVs) and point mutations and revealing cell-to-cell heterogeneity in biological materials. They are employed to investigate both healthy and diseased physiology.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Based Assays Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

    Cell Culture Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Single-Cell Genome Sequencing Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Global Single-Cell Genome Sequencing Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    At What Rate is the Single-Cell Genome Sequencing Market Predicted to Expand Between 2024 and 2033?

    The market size for single-cell genome sequencing has expanded swiftly in the past few years. It is likely to swell from $2.17 billion in 2023 to $2.47 billion in 2024, marking a compound annual growth rate (CAGR) of 14.3%. The notable growth during the past era is due to an enhanced comprehension of genetic diversity, a surge in demand for precision medicine, an upswing in cancer research, an escalation in the occurrence of infectious diseases, and increased expenditure on healthcare.

    Expectations are high for the single-cell genome sequencing market to witness accelerated expansion in the coming years. The market size is predicted to reach $4.27 billion in 2028, with a compound annual growth rate (CAGR) of 14.6%. Several factors are set to boost this growth during the forecast period, including the rising incidences of autoimmune diseases and neurological disorders, increased government initiatives and funding, the emergence of contract research organizations (CROs), and enhanced awareness of the potential of scrna-seq. Key market trends in this period encompass technology advancements in single-cell sequencing, expansion of single-cell multi-omics technologies, joint initiatives for raging advancements, innovative solutions, and strategic partnerships among leading players.

    Claim Your Free Sample of the Global Single-Cell Genome Sequencing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

    What Forces Are Boosting the single-cell genome sequencing Market’s Growth?

    The rise in cancer cases is predicted to drive the expansion of the single-cell genome sequencing market. Cancer encompasses a wide spectrum of diseases wherein rogue cells multiply and divide in an unregulated manner due to genetic modifications that interfere with cell division and normal cell operations. Cancer is marked by genetic alterations, hence single-cell genome sequencing can be utilized to identify these genetic modifications in individual cancer cells. For instance, in January 2023, the American Cancer Society, a US-based organization combatting cancer, reported approximately 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US in 2022. In addition, by 2040, it is forecasted that there will be nearly 27.5 million new cancer diagnoses and 16.3 million cancer deaths. As a result of the escalating cancer prevalence, the single-cell genome sequencing market is expected to experience growth.

    What Key Segments Make Up the Single-Cell Genome Sequencing Market?

    1) By Type: Instruments, Reagents

    2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)

    3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas

    4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications

    5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

    What Are the Latest Trends Impacting the Single-Cell Genome Sequencing Market?

    Innovations in technology are becoming an increasingly popular trend within the single-cell genome sequencing market. Most prominent businesses in this market are concentrating on designing state-of-the-art solutions in order to reinforce their standing. To illustrate, Mission Bio Inc., an American company specializing in single-cell multi-omics platforms for both cancer research and biomarker creation, launched the Tapestri Genome Editing Solution in May 2023. This novel approach is expected to provide a more efficient analytical tool for the production of next-generation gene-edited drugs. It does so by offering single-cell insights that can influence both effectiveness and safety.

    Order Now for Fast Delivery of Your Single-Cell Genome Sequencing Market Report!

    https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

    What Regions Are Dominating the Single-Cell Genome Sequencing Market Growth?

    North America was the largest region in the single-cell genome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Single-Cell Genome Sequencing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the single-cell genome sequencing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Single-Cell Genome Sequencing Market Include

    1. Single-Cell Genome Sequencing Market Executive Summary

    2. Single-Cell Genome Sequencing Market Segments

    3. Single-Cell Genome Sequencing Market Size And Template Market Growth Rate

    4. Key Single-Cell Genome Sequencing Market Trends

    5. Major Single-Cell Genome Sequencing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Single-Cell Genome Sequencing Market

    26. Top Single-Cell Genome Sequencing Companies

    27. Single-Cell Genome Sequencing Market Opportunities And Strategies

    28. Single-Cell Genome Sequencing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Cell and Gene Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

    Next Generation Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

    NGS-Based RNA-Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Single-Cell Genome Sequencing Market Growth Analysis Till 2033 By The Business Research Company

    Single-Cell Genome Sequencing Market Growth Analysis Till 2033 By The Business Research Company

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    • Historical Growth Drivers
      • Increased understanding of genetic heterogeneity
      • Rising demand for precision medicine
      • Increased cancer research
      • Growth in prevalence of infectious diseases
      • Increased healthcare spending
    • Forecasted Growth Drivers
      • Increasing prevalence of autoimmune diseases
      • Increasing neurological disorders
      • Increasing government initiatives and funding
      • Rise of contract research organizations (CROs)
      • Increasing awareness of scRNA-seq’s potential

    Read More On The Single-Cell Genome Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

    Rising Cancer Prevalence Drives Growth In Single-Cell Genome Sequencing Market

    The increasing prevalence of cancer is expected to propel the growth of the single-cell genome sequencing market. Cancer, characterized by genetic alterations, can be better understood through single-cell genome sequencing, revealing genetic changes in individual cancer cells. According to the American Cancer Society, there were around 1.9 million new cancer cases and 609,360 cancer deaths in the US in 2022, with projections estimating 27.5 million new cases and 16.3 million deaths by 2040.

    Technological Advancements Drive Innovations In Single-Cell Genome Sequencing Market

    Technological advancements are a key trend in the single-cell genome sequencing market. Companies are focused on developing advanced solutions. For example, Mission Bio Inc. introduced the Tapestri Genome Editing Solution, offering single-cell insights for developing next-generation gene-edited drugs.

    Illumina’s Acquisition Of Grail Pioneering Advancements In Genomic Healthcare

    In August 2021, Illumina Inc. acquired GRAIL, a biotechnology company specializing in whole-genome sequencing. This acquisition aims to revolutionize healthcare, including cancer detection and treatment.

    Market Segmentation

    The single-cell genome sequencing market is segmented by:

    • Type
      • Instruments
      • Reagents
    • Technology
      • Next-Generation Sequencing (NGS)
      • Polymerase Chain Reaction (PCR)
      • Quantitative Polymerase Chain Reaction (qPCR)
      • Microarray
      • Multiple Displacement Amplification (MDA)
    • Disease Area
      • Cancer
      • Immunology
      • Prenatal Diagnosis
      • Neurobiology
      • Microbiology
      • Other Disease Areas
    • Application
      • Circulating Cells
      • Cell Differentiation Or Reprogramming
      • Genomic Variation
      • Subpopulation Characterization
      • Other Applications
    • End User
      • Academic Research Laboratories
      • Biotechnology Biopharmaceutical Companies
      • Clinics
      • Other End Users

    Regional Analysis

    North America was the largest region in the single-cell genome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

    Request for A Sample Of The Global Single-Cell Genome Sequencing Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=12655&type=smp